
Cardiac Rhythm Management Market Size, Share, & COVID-19 Impact Analysis | Global | 2022-2028 | MedSuite | Includes: Pacemakers, Cardiac Ablation Catheters, and 6 more
- Year: 2022
- Scope: 10 Years
- Region: Global
- Pages: 755
- Published Date: 11/24/2022
- Type: MedSuite
Overall, the global cardiac rhythm management, electrophysiology & cardiac ablation market was valued at nearly $17.5 billion in 2021. This is expected to increase over the forecast period at a CAGR of 4.9% to reach over $24 billion.
The full report suite on the global market for cardiac rhythm management, electrophysiology & cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, implantable loop recorders (ILRs), electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET TRENDS
New technologies are constantly emerging in cardiac rhythm management and ablation. The capabilities and battery lifespan of pacemakers and ICDs have increased in the last decade. Over the forecast period, wireless technology is expected to make it easier for doctors to maintain and adjust pacemaker and ICD function. In addition, new technologies are expected to keep selling prices high and lead to a higher number of devices sold.
GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET SHARE INSIGHTS
Out of 60+ cardiac rhythm management device companies analyzed, the global market share is dominated by three key players – Medtronic, Abbott, Boston Scientific.
Medtronic has maintained a strong presence in the total market for cardiac rhythm management (CRM), electrophysiology (EP) and ablation through brand recognition, strong customer support and a large sales force.
MARKET SEGMENTATION SUMMARY
While this report suite contains all global cardiac rhythm management devices data, each of the markets is also available as a stand-alone report, a MedCore.
- Pacemaker Market – Includes:
- Single-Chamber Pacemaker, Dual-Chamber Pacemaker, and Leadless Pacemaker
- Implantable Cardioverter Defibrillator Market – Includes:
- Single-Chamber ICD, Dual-Chamber ICD, and S-ICDs
- Cardiac Resynchronization Therapy Device Market – Includes:
- CRT-P, CRT-D
- Cardiac Lead Market – Includes:
- Pacing Lead, Defibrillation Lead, and LV Lead
- Implant Loop Recorder Market
- Electrophysiology Lab System Market – Includes:
- 3D Mapping System, EP Recording System
- Diagnostic Electrophysiology Catheter Market – Includes:
- Conventional EP Catheter, Advanced EP Catheter, and ICE Catheter
- Cardiac Ablation Catheter Market – Includes:
- RF Ablation Catheter, Cryoablation Catheter
RESEARCH SCOPE SUMMARY
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2021 |
Forecast | 2021-2028 |
Historical Data | 2018-2021 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
Table of Contents
TABLE of CONTENTS |
List of Figures |
List of Charts |
executive summary |
Global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview |
Competitive Analysis |
Market Trends |
Market Developments |
Procedures Included |
Markets Included |
Regions Included |
Version History |
research methodology |
Step 1: Project Initiation & Team Selection |
Step 2: Prepare Data Systems and Perform Secondary Research |
Step 3: Preparation for Interviews & Questionnaire Design |
Step 4: Performing Primary Research |
Step 5: Research Analysis: Establishing Baseline Estimates |
Step 6: Market Forecast and Analysis |
Step 7: Identify Strategic Opportunities |
Step 8: Final Review and Market Release |
Step 9: Customer Feedback and Market Monitoring |
impact of covid-19 on THE global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market |
2.1 Introduction |
2.2 Regional Profiles |
2.3 Analysis By Market Segment |
2.3.1 Worst Case Scenario |
2.3.2 Base Case Scenario |
2.3.3 Best Case Scenario |
Disease Overview |
3.1 Introduction |
3.2 Types of Arrhythmias |
3.2.11 Atrial Fibrillation |
3.2.12 Bradycardia |
3.2.13 Conduction Disorders |
3.2.13.1 Bundle Branch Block |
3.2.13.2 Heart Block |
3.2.13.3 Long QT Syndrome (LQTS) |
3.2.14 Premature Contractions: PACs and PVCs |
3.2.15 Tachycardia |
3.2.16 Ventricular Fibrillation |
3.2.17 Other Rhythm Disorders |
3.2.17.1 Adams-Stokes Disease |
3.2.17.2 Atrial Flutter |
3.2.17.3 Sick Sinus syndrome |
3.2.17.4 Sinus Arrhythmia |
3.2.17.5 Wolff-Parkinson-White Syndrome (WPW) |
3.2.18 Types of Arrhythmia in Children |
3.3 Heart Failure |
3.4 Cardiac Arrest |
3.5 Patient Demographics |
3.5.11 Atrial Fibrillation |
3.5.12 Bradycardia |
3.5.13 Conduction Disorders |
3.5.14 Premature Contractions – PACs and PVCs |
3.5.15 Tachycardia |
3.5.16 Ventricular Fibrillation |
3.5.17 Other Rhythm Disorders |
3.5.18 COVID & Arrhythmias |
3.5.19 Heart Failure and Cardiac Arrest |
Product Assessment |
4.1 Introduction |
4.2 Product Portfolios |
4.2.1 Pacemakers |
4.2.2 Implantable Cardioverter Defibrillators (ICDs) |
4.2.3 Cardiac Resynchronization Therapy (CRT) Devices |
4.2.4 Cardiac Leads |
4.2.5 Implantable Loop Recorders |
4.2.6 Electrophysiology Lab Systems |
4.2.6.1 Introduction |
4.2.6.2 3D Mapping Systems |
4.2.6.3 EP Recording Systems |
4.2.6.4 Remote Steering Systems |
4.2.6.5 RF Ablation Generator |
4.2.6.6 ICE Systems |
4.2.7 Diagnostic EP Catheters |
4.2.7.1 Introduction |
4.2.7.2 Diagnostic EP Catheters |
4.2.7.3 ICE Catheters |
4.2.8 Cardiac Ablation Catheters |
4.2.8.1 Introduction |
4.2.8.2 RF Ablation Catheters |
4.2.8.3 Alternative Energy Catheters |
4.2.8.4 High Intensity Focused Ultrasound |
4.3 Regulatory Issues and Recalls |
4.3.1 Abbott |
4.3.1.1 Pacemakers |
4.3.1.2 Implantable Cardioverter Defibrillators (ICDs) |
4.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices |
4.3.1.4 Cardiac Leads |
4.3.1.5 EP Lab Devices |
4.3.1.6 Cardiac Ablation Catheter |
4.3.2 Biosense Webster |
4.3.2.1 EP Lab Devices |
4.3.2.2 Diagnostic EP Catheters |
4.3.2.3 Cardiac Ablation Catheters |
4.3.3 Boston Scientific |
4.3.3.1 Pacemakers |
4.3.3.2 Implantable Cardioverter Defibrillators (ICDs) |
4.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices |
4.3.3.4 Cardiac Leads |
4.3.3.5 EP Lab Devices |
4.3.3.6 RF Ablation Catheter |
4.3.4 Medtronic |
4.3.4.1 Pacemakers |
4.3.4.2 Implantable Cardioverter Defibrillators (ICDs) |
4.3.4.3 Cardiac Resynchronization Therapy (CRT) Devices |
4.3.4.4 Cardiac Leads |
4.3.4.5 EP Lab Devices |
4.3.5 MicroPort |
4.3.5.1 Implantable Cardioverter Defibrillators (ICDs) |
4.3.5.2 Cardiac Resynchronization Therapy (CRT) Devices |
4.4 Clinical Trials |
4.4.1 Pacemakers |
4.4.2 Implantable Cardioverter Defibrillators (ICDs) |
4.4.3 Cardiac Resynchronization Therapy (CRT) Devices |
4.4.4 Cardiac Leads |
4.4.5 Lab Systems |
4.4.5.1 3D Mapping Systems |
4.4.5.2 EP Recording Systems |
4.4.5.3 RF Ablation Generators |
4.4.5.4 ICE Systems |
4.4.6 Diagnostic EP Catheters |
4.4.6.1 Diagnostic Catheter |
4.4.7 Cardiac Ablation Catheter |
4.4.7.1 RF Ablation Catheters |
4.4.7.2 Cryoablation Catheters |
4.4.7.4 Laser Ablation Catheters |
Global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview |
5.1 Introduction |
5.2 Market Overview & Trend Analysis |
5.2.1 By Segment |
5.2.2 By Region |
5.3 Drivers and Limiters |
5.3.1 Market Drivers |
5.3.2 Market Limiters |
5.4 Competitive Market Share Analysis |
5.5 Mergers and Acquisitions |
5.6 Company Profiles |
5.6.1 Abbott |
5.6.2 Biosense Webster |
5.6.3 Biotronik |
5.6.4 Boston Scientific |
5.6.5 GE Healthcare |
5.6.6 Medtronic |
5.6.7 MicroPort |
5.7 SWOT Analysis |
5.7.1 Abbott |
5.7.2 Biosense Webster |
5.7.3 Biotronik |
5.7.4 Boston Scientific |
5.7.5 GE Healthcare |
5.7.6 Medtronic |
5.7.7 MicroPort |
Pacemaker Market |
6.1 Executive Summary |
6.1.1 Global Pacemaker Market Overview |
6.1.2 Competitive Analysis |
6.1.3 Procedures Included |
6.1.4 Markets Included |
6.1.5 Regions Included |
6.2 Introduction |
6.2.1 Single and Dual-Chamber Devices |
6.2.2 MRI-Compatible Pacemaker |
6.2.3 Leadless Pacemaker |
6.2.4 Initial Placement and Replacement of Pacemakers |
6.3 Procedure Numbers |
6.3.1 Total Pacemaker Placement Procedures |
6.3.2 Initial Placement Pacemaker Procedures |
6.3.3 Replacement Pacemaker Procedures |
6.4 Market Overview |
6.4.1 By Segment |
6.4.2 By Region |
6.5 Market Analysis and Forecast |
6.5.1 Total Pacemaker Market |
6.5.2 Single-Chamber Pacemaker Market |
6.5.2.1 Initial Placement Single-Chamber Pacemaker Market |
6.5.2.2 Replacement Single-Chamber Pacemaker Market |
6.5.3 Dual-Chamber Pacemaker Market |
6.5.3.1 Initial Placement Dual-Chamber Pacemaker Market |
6.5.3.2 Replacement Dual-Chamber Pacemaker Market |
6.5.4 Leadless Pacemaker Market |
6.5.4.1 Initial Placement Leadless Pacemaker Market |
6.5.4.2 Replacement Leadless Pacemaker Market |
6.6 Drivers and Limiters |
6.6.1 Market Drivers |
6.6.2 Market Limiters |
6.7 Competitive Market Share Analysis |
Implantable Cardioverter defibrillator Market |
7.1 Executive Summary |
7.1.1 Global Implantable Cardioverter Defibrillator Market Overview |
7.1.2 Competitive Analysis |
7.1.3 Procedures Included |
7.1.4 Markets Included |
7.1.5 Regions Included |
7.2 Introduction |
7.3 Procedure Numbers |
7.3.1 Total ICD Placement Procedures |
7.3.2 Initial Placement ICD Procedures |
7.3.3 Replacement ICD Procedures |
7.4 Market Overview |
7.4.1 By Segment |
7.4.2 By Region |
7.5 Market Analysis and Forecast |
7.5.1 Total ICD Market |
7.5.2 Single-Chamber ICD Market |
7.5.2.1 Initial Placement Single-Chamber ICD Market |
7.5.2.2 Replacement Single-Chamber ICD Market |
7.5.3 Dual-Chamber ICD Market |
7.5.3.1 Initial Placement Dual-Chamber ICD Market |
7.5.3.2 Replacement Dual-Chamber ICD Market |
7.5.4 S-ICD Market |
7.5.4.1 Initial Placement S-ICD Market |
7.5.4.2 Replacement S-ICD Market |
7.6 Drivers and Limiters |
7.6.1 Market Drivers |
7.6.2 Market Limiters |
7.7 Competitive Market Share Analysis |
Cardiac Resynchronization Therapy Device Market |
8.1 Executive Summary |
8.1.1 Global Cardiac Resynchronization Therapy Device Market Overview |
8.1.2 Competitive Analysis |
8.1.3 Procedures Included |
8.1.4 Markets Included |
8.1.5 Regions Included |
8.2 Introduction |
8.2.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) |
8.2.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) |
8.3 Procedure Numbers |
8.3.1 Total CRT Placement Procedures |
8.3.2 Initial Placement CRT Procedures |
8.3.3 Replacement CRT Procedures |
8.4 Market Overview |
8.4.1 By Segment |
8.4.2 By Region |
8.5 Market Analysis and Forecast |
8.5.1 Total CRT Device Market |
8.5.2 CRT-P Market |
8.5.2.1 Initial Placement CRT-P Market |
8.5.2.2 Replacement CRT-P Market |
8.5.3 CRT-D Market |
8.5.3.1 Initial Placement CRT-D Market |
8.5.3.2 Replacement CRT-D Market |
8.6 Drivers and Limiters |
8.6.1 Market Drivers |
8.6.2 Market Limiters |
8.7 Competitive Market Share Analysis |
Cardiac Lead Market |
9.1 Executive Summary |
9.1.1 Global Cardiac Lead Market Overview |
9.1.2 Competitive Analysis |
9.1.3 Markets Included |
9.1.4 Regions Included |
9.2 Introduction |
9.2.1 Replacement of Leads |
9.3 Market Overview |
9.3.1 By Segment |
9.3.2 By Region |
9.4 Market Analysis and Forecast |
9.4.1 Total Cardiac Lead Market |
9.4.2 Pacing Lead Market |
9.4.3 Defibrillation Lead Market |
9.4.4 LV Lead Market |
9.5 Drivers and Limiters |
9.5.1 Market Drivers |
9.5.2 Market Limiters |
9.6 Competitive Market Share Analysis |
Implantable Loop Recorder Market |
10.1 Executive Summary |
10.1.1 Global Implantable Loop Recorder Market Overview |
10.1.2 Competitive Analysis |
10.1.3 Regions Included |
10.2 Introduction |
10.3 Procedure Numbers |
10.4 Market Analysis and Forecast |
10.5 Drivers and Limiters |
10.5.1 Market Drivers |
10.5.2 Market Limiters |
10.6 Competitive Market Share Analysis |
Electrophysiology Lab System Market |
11.1 Executive Summary |
11.1.1 Global Electrophysiology Lab System Market Overview |
11.1.2 Competitive Analysis |
11.1.3 Markets Included |
11.1.4 Regions Included |
11.2 Introduction |
11.2.1 3D Mapping Systems |
11.2.2 EP Recording Systems |
11.3 Market Overview |
11.3.1 By Segment |
11.3.2 By Region |
11.4 Market Analysis and Forecast |
11.4.1 Total Electrophysiology Lab System Market |
11.4.2 3D Mapping System Market |
11.4.3 EP Recording System Market |
11.5 Drivers and Limiters |
11.5.1 Market Drivers |
11.5.2 Market Limiters |
11.6 Competitive Market Share Analysis |
Diagnostic Electrophysiology Catheter Market |
12.1 Executive Summary |
12.1.1 Global Diagnostic Electrophysiology Catheter Market Overview |
12.1.2 Competitive Analysis |
12.1.3 Markets Included |
12.1.4 Regions Included |
12.2 Introduction |
12.2.1 Diagnostic Electrophysiology Catheters |
12.2.2 Intracardiac Echocardiography |
12.3 Procedure Numbers |
12.4 Market Overview |
12.4.1 By Segment |
12.4.2 By Region |
12.5 Market Analysis and Forecast |
12.5.1 Total Diagnostic Electrophysiology Catheter Market |
12.5.2 Conventional Electrophysiology Catheter Market |
12.5.3 Advanced Electrophysiology Catheter Market |
12.5.4 ICE Catheter Market |
12.6 Drivers and Limiters |
12.6.1 Market Drivers |
12.6.2 Market Limiters |
12.7 Competitive Market Share Analysis |
Cardiac Ablation Catheter Market |
13.1 Executive Summary |
13.1.1 Global Cardiac Ablation Catheter Market Overview |
13.1.2 Competitive Analysis |
13.1.3 Procedures Included |
13.1.4 Markets Included |
13.1.5 Regions Included |
13.2 Introduction |
13.3 Procedure Numbers |
13.3.1 Total Cardiac Ablation Procedures |
13.3.2 RF Ablation Procedures |
13.3.3 Cryoablation Procedures |
13.4 Market Overview |
13.4.1 By Segment |
13.4.2 By Region |
13.5 Market Analysis and Forecast |
13.5.1 Total Cardiac Ablation Catheter Market |
13.5.2 RF Ablation Catheter Market |
13.5.3 Cryoablation Catheter Market |
13.6 Drivers and Limiters |
13.6.1 Market Drivers |
13.6.2 Market Limiters |
13.7 Competitive Market Share Analysis |
Abbreviations |
Companies Included:
· Abbott | · Lepu Medical |
· Angel Medical Systems | · Medico |
· AngioDynamics | · Medtronic |
· AtriCure | · MicroPort |
· Biosense Webster | · Pacetronix |
· Biotronik | · Philips |
· Boston Scientific | · Schwarzer Cardiotek |
· CathVision | · Siemens |
· GE Healthcare | · Stereotaxis |
· Imricor Medical Systems | · Vectorious |
· JJET |
List of Charts
Chart 1‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2021 – 2028 |
Chart 1‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures, Global, 2021 |
Chart 2‑1: Multi-Scenario Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Forecast, Global, 2018 – 2028 (US$M) |
Chart 5‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2018 – 2028 |
Chart 5‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Region, Global, 2018 – 2028 |
Chart 5‑3: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2021 |
Chart 6‑1: Pacemaker Market, Global, 2018 – 2028 |
Chart 6‑2: Pacemaker Placement Procedures, Global, 2021 |
Chart 6‑3: Pacemaker Placement Procedures by Segment, Global, 2018 – 2028 |
Chart 6‑4: Pacemaker Market by Segment, Global, 2018 – 2028 |
Chart 6‑5: Pacemaker Market by Region, Global, 2018 – 2028 |
Chart 6‑6: Leading Competitors, Pacemaker Market, Global, 2021 |
Chart 7‑1: ICD Market, Global, 2018 – 2028 |
Chart 7‑2: ICD Placement Procedures, Global, 2021 |
Chart 7‑3: ICD Placement Procedures by Segment, Global, 2018 – 2028 |
Chart 7‑4: ICD Market by Segment, Global, 2018 – 2028 |
Chart 7‑5: ICD Market by Region, Global, 2018 – 2028 |
Chart 7‑6: Leading Competitors, ICD Market, Global, 2021 |
Chart 8‑1: CRT Device Market, Global, 2018 – 2028 |
Chart 8‑2: CRT Device Placement Procedures, Global, 2021 |
Chart 8‑3: CRT Placement Procedures by Segment, Global, 2018 – 2028 |
Chart 8‑4: CRT Device Market by Segment, Global, 2018 – 2028 |
Chart 8‑5: CRT Device Market by Region, Global, 2018 – 2028 |
Chart 8‑6: Leading Competitors, CRT Device Market, Global, 2021 |
Chart 9‑1: Cardiac Lead Market, Global, 2018 – 2028 |
Chart 9‑2: Cardiac Lead Units Sold, Global, 2021 |
Chart 9‑3: Cardiac Lead Market by Segment, Global, 2018 – 2028 |
Chart 9‑4: Cardiac Lead Market by Region, Global, 2018 – 2028 |
Chart 9‑5: Leading Competitors, Cardiac Lead Market, Global, 2021 |
Chart 10‑1: Implantable Loop Recorder Market, Global, 2018 – 2028 |
Chart 10‑2: Implantable Loop Recorder Placement Procedures, Global, 2021 |
Chart 10‑3: Implantable Loop Recorder Placement Procedures by Region, Global, 2018 – 2028 |
Chart 10‑4: Implantable Loop Recorder Device Market, Global, 2018 – 2028 |
Chart 10‑5: Leading Competitors, Implantable Loop Recorder Market, Global, 2021 |
Chart 11‑1: Electrophysiology Lab System Market, Global, 2018 – 2028 |
Chart 11‑2: Electrophysiology Lab System Procedures, Global, 2021 |
Chart 11‑3: Electrophysiology Lab System Market by Segment, Global, 2018 – 2028 |
Chart 11‑4: Electrophysiology Lab System Market by Region, Global, 2018 – 2028 |
Chart 11‑5: Leading Competitors, Electrophysiology Lab System Market, Global, 2021 |
Chart 12‑1: Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 |
Chart 12‑2: Diagnostic Electrophysiology Catheter Procedures, Global, 2021 |
Chart 12‑3: Diagnostic Electrophysiology Procedures, Global, 2018 – 2028 |
Chart 12‑4: Diagnostic Electrophysiology Catheter Market by Segment, Global, 2018 – 2028 |
Chart 12‑5: Diagnostic Electrophysiology Catheter Market by Region, Global, 2018 – 2028 |
Chart 12‑6: Leading Competitors, Diagnostic Electrophysiology Catheter Market, Global, 2021 |
Chart 13‑1: Cardiac Ablation Catheter Market, Global, 2018 – 2028 |
Chart 13‑2: Cardiac Ablation Catheter Procedures, Global, 2021 |
Chart 13‑3: Cardiac Ablation Procedures by Segment, Global, 2018 – 2028 |
Chart 13‑4: Cardiac Ablation Catheter Market by Segment, Global, 2018 – 2028 |
Chart 13‑5: Cardiac Ablation Catheter Market by Region, Global, 2018 – 2028 |
Chart 13‑6: Leading Competitors, Cardiac Ablation Catheter Market, Global, 2021 |
List of Figures
Figure 1‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Global, 2021 (1 of 2) |
Figure 1‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Global, 2021 (2 of 2) |
Figure 1‑3: Companies Researched in this Report |
Figure 1‑4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global (1 of 2) |
Figure 1‑5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global (2 of 2) |
Figure 1‑6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 – 2022 (1 of 2) |
Figure 1‑7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 – 2022 (2 of 2) |
Figure 1‑8: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered |
Figure 1‑9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (1 of 2) |
Figure 1‑10: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (2 of 2) |
Figure 1‑11: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Regions Covered, Global (1 of 2) |
Figure 1‑12: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Regions Covered, Global (2 of 2) |
Figure 1‑13: Version History |
Figure 2‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Worst Case Scenario, Global, 2018 – 2028 (US$M) |
Figure 2‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Base Case Scenario, Global, 2018 – 2028 (US$M) |
Figure 2‑3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Best Case Scenario, Global, 2018 – 2028 (US$M) |
Figure 4‑1: Pacemaker Market Products by Company |
Figure 4‑2: ICD Market Products by Company |
Figure 4‑3: CRT Device Market Products by Company (1 of 2) |
Figure 4‑4: CRT Device Market Products by Company (2 of 2) |
Figure 4‑5: Cardiac Lead Market Products by Company |
Figure 4‑6: Implantable Loop Recorder Market Products by Company |
Figure 4‑7: EP Lab System Market Products by Company |
Figure 4‑8: Diagnostic EP Catheter Market Products by Company |
Figure 4‑9: Cardiac Ablation Catheter Products by Company (1 of 2) |
Figure 4‑10: Cardiac Ablation Catheter Products by Company (2 of 2) |
Figure 4‑11: Class 1 Device Recall Assurity pacemakers |
Figure 4‑12: Class 1 Device Recall St. Jude Endurity Pacemakers |
Figure 4‑13: Class 1 Device Recall Fortify, Unify, Assura, including Quadra |
Figure 4‑14: Class 2 Device Recall Ellipse |
Figure 4‑15: Class 2 Device Recall Quadra Assura |
Figure 4‑16: Class 2 Device Recall Unify Assura |
Figure 4‑17: Class 2 Device Recall Unify Quadra |
Figure 4‑18: Class 2 Device Recall Promote Quadra |
Figure 4‑19: Class 2 Device Recall Allure Quadra |
Figure 4‑20: Class 2 Device Recall Allure Quadra |
Figure 4‑21: Class 2 Device Recall Anthem, Allure |
Figure 4‑22: Class 2 Device Recall Nuance |
Figure 4‑23: Class 1 Device Recall Optisure HV lead |
Figure 4‑24: Class 2 Device Recall FIRMap |
Figure 4‑25: Class 2 Device Recall WorkMate Claris, v.1.2 Upgrade Kits |
Figure 4‑26: Class 3 Device Recall FIRMap 60mm Catheter |
Figure 4‑27: Class 2 Device Recall Abbott |
Figure 4‑28: Class 2 Device Recall TactiSys Quartz Pack, PN004 400 |
Figure 4‑29: Class 2 Device Recall CARTO 3 System |
Figure 4‑30: Class 2 Device Recall SMARTABLATE RF Generator System |
Figure 4‑31: Class 2 Device Recall ACUSON AcuNav Volume ICE Catheter |
Figure 4‑32: Class 2 Device Recall PENTARAY NAV eco HighDensity Mapping Catheter |
Figure 4‑33: Class 2 Device Recall PENTARAY NAV HighDensity Mapping Catheter |
Figure 4‑34: Class 2 Device Recall SOUNDSTAR eco Catheter |
Figure 4‑35: Class 2 Device Recall WEBSTER Fixed Curve Catheter with Auto ID Technology |
Figure 4‑36: Class 2 Device Recall THERMOCOOL SMARTTOUCH |
Figure 4‑37: Class 1 Device Recall ADVANTIO DR EL |
Figure 4‑38: Class 1 Device Recall INGENIO DR EL |
Figure 4‑39: Class 1 Device Recall VITALIO DR EL |
Figure 4‑40: Class 2 Device Recall Accolade |
Figure 4‑41: Class 2 Device Recall Essentio |
Figure 4‑42: Class 2 Device Recall EMBLEM |
Figure 4‑43: Class 1 Device Recall EMBLEM |
Figure 4‑44: Class 2 Device Recall ESSENTIO Pacemaker |
Figure 4‑45: Class 2 Device Recall PROPONENT Pacemaker |
Figure 4‑46: Class 2 Device Recall ACCOLADE Pacemaker |
Figure 4‑47: Class 2 Device Recall ACCOLADE MRI Pacemaker |
Figure 4‑48: Class 2 Device Recall ESSENTIO MRI Pacemaker |
Figure 4‑49: Class 2 Device Recall ESSENTIO Pacemaker |
Figure 4‑50: Class 2 Device Recall PROPONENT Pacemaker |
Figure 4‑51: Class 2 Device Recall PROPONENT MRI Pacemaker |
Figure 4‑52: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker |
Figure 4‑53: Class 2 Device Recall ALTRUA 2 SR Pacemaker |
Figure 4‑54: Class 2 Device Recall ALTRUA 2 DR Pacemaker |
Figure 4‑55: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers |
Figure 4‑56: Class 2 Device Recall EMBLEM |
Figure 4‑57: Class 2 Device Recall EMBLEM |
Figure 4‑58: Class 1 Device Recall EMBLEM |
Figure 4‑59: Class 2 Device Recall DYNAGEN EL ICD DR |
Figure 4‑60: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT) |
Figure 4‑61: Class 2 Device Recall RESONATE EL ICD VR/DR |
Figure 4‑62: Class 2 Device Recall EMBLEM SICD, Model A209 |
Figure 4‑63: Class 2 Device Recall SQRX 1010 Pulse Generator |
Figure 4‑64: Class 2 Device Recall EMBLEM MRI SICD Model 219 |
Figure 4‑65: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator |
Figure 4‑66: Class 1 Device Recall INTUA CRTP |
Figure 4‑67: Class 1 Device Recall INVIVE CRTP |
Figure 4‑68: Class 2 Device Recall VISIONIST CRTP |
Figure 4‑69: Class 2 Device Recall VALITUDE CRTP |
Figure 4‑70: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker) |
Figure 4‑71: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker |
Figure 4‑72: Class 2 Device Recall VALITUDE CRTP Pacemaker |
Figure 4‑73: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker |
Figure 4‑74: Class 2 Device Recall VISIONIST CRTP Pacemaker |
Figure 4‑75: Class 2 Device Recall RESONATE X4 CRTD |
Figure 4‑76: Class 2 Device Recall MOMENTUM X4 CRTD |
Figure 4‑77: Class 2 Device Recall VIGILANT X4 CRTD |
Figure 4‑78: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly |
Figure 4‑79: Class 2 Device Recall iLab Polaris MultiModality Guidance System |
Figure 4‑80: Class 2 Device Recall Maestro 4000 Cardiac Ablation System |
Figure 4‑81: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System |
Figure 4‑82: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters |
Figure 4‑83: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter |
Figure 4‑84: Class 2 Device Recall Astra XT DR Implantable pulse generator |
Figure 4‑85: Class 2 Device Recall Azure |
Figure 4‑86: Class 2 Device Recall Azure XT DR MRI |
Figure 4‑87: Class 2 Device Recall Azure S DR MRI |
Figure 4‑88: Class 2 Device Recall Azure XT SR MRI |
Figure 4‑89: Class 2 Device Recall Azure S SR MRI |
Figure 4‑90: Class 2 Device Recall Medtronic Micra MC1VR01 |
Figure 4‑91: Class 1 Device Recall SPHERA, Dual chamber pacemaker |
Figure 4‑92: Class 1 Device Recall SENSIA, Dual chamber pacemaker |
Figure 4‑93: Class 1 Device Recall VERSA, Dual chamber pacemaker |
Figure 4‑94: Class 1 Device Recall ADAPTA, Dual chamber pacemaker |
Figure 4‑95: Class 1 Device Recall ATTESTA L DR MRI SureScan, Dual chamber rate responsive pacemaker |
Figure 4‑96: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator |
Figure 4‑97: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse Generator |
Figure 4‑98: Class 1 Device Recall Cobalt |
Figure 4‑99: Class 1 Device Recall Crome |
Figure 4‑100: Class 1 Device Recall Evera and Visia |
Figure 4‑101: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies |
Figure 4‑102: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies |
Figure 4‑103: Class 2 Device Recall Medtronic EnTrust Escudo |
Figure 4‑104: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD |
Figure 4‑105: Class 1 Device Recall Visia AF MRI VR SureScan ICD |
Figure 4‑106: Class 1 Device Recall Visia AF VR ICD |
Figure 4‑107: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD |
Figure 4‑108: Class 2 Device Recall Evera ICD |
Figure 4‑109: Class 2 Device Recall Viva ICD |
Figure 4‑110: Class 1 Device Recall Cobalt |
Figure 4‑111: Class 1 Device Recall Crome |
Figure 4‑112: Class 2 Device Recall Cobalt |
Figure 4‑113: Class 2 Device Recall Precepta |
Figure 4‑114: Class 2 Device Recall Percepta, Serena, and Solara CRTP MRI |
Figure 4‑115: Class 1 Device Recall Viva, Claria, Amplia, Compia, and Brava |
Figure 4‑116: Class 2 Device Recall Percepta CRTP MRI |
Figure 4‑117: Class 2 Device Recall Solara CRTP MRI |
Figure 4‑118: Class 2 Device Recall Serena CRTP MRI |
Figure 4‑119: Class 2 Device Recall Percepta CRTP MRI SureScan |
Figure 4‑120: Class 2 Device Recall Percepta Quad CRTP MRI SureScan |
Figure 4‑121: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD |
Figure 4‑122: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD |
Figure 4‑123: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD |
Figure 4‑124: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD SureScanCompia MRI Quad CRTD SureScan |
Figure 4‑125: Class 2 Device Recall InSync III |
Figure 4‑126: Class 2 Device Recall Sprint Quattro |
Figure 4‑127: Class 2 Device Recall Medtronic, Temporary Pacing Lead System |
Figure 4‑128: Class 2 Device Recall Achieve Electrical Cable |
Figure 4‑129: Class 2 Device Recall Medtronic CryoConsole |
Figure 4‑130: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator |
Figure 4‑131: Class 2 Device Recall Platinium DR 1510 |
Figure 4‑132: Class 2 Device Recall Platinium VR 1210 |
Figure 4‑133: Class 2 Device Recall Platinium DR DF4 1540 |
Figure 4‑134: Class 2 Device Recall Platinium VR DF4 1240 |
Figure 4‑135: Class 2 Device Recall PARADYM |
Figure 4‑136: Class 2 Device Recall OVATIO |
Figure 4‑137: Class 2 Device Recall INTENSIA |
Figure 4‑138: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator |
Figure 4‑139: Class 2 Device Recall Platinium CRTD 1741 |
Figure 4‑140: Class 2 Device Recall Platinium CRT DF1 1711 |
Figure 4‑141: Class 2 Device Recall PARADYM |
Figure 4‑142: Class 2 Device Recall OVATIO |
Figure 4‑143: Class 2 Device Recall INTENSIA |
Figure 4‑144: The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System |
Figure 4‑145: Aveir VR Coverage With Evidence Development Post-Approval Study (CED) |
Figure 4‑146: A Retrospective Trial to Evaluate the Micra Pacemaker (Micra) |
Figure 4‑147: Project My Heart Your Heart: Pacemaker Reuse (MHYH) |
Figure 4‑148: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study) |
Figure 4‑149: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers |
Figure 4‑150: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan |
Figure 4‑151: BIO|MASTER.Edora Family Study |
Figure 4‑152: China Micra Transcatheter Pacing Study |
Figure 4‑153: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study) |
Figure 4‑154: Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation - The CAPAPAF-65 Study |
Figure 4‑155: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II |
Figure 4‑156: Observation of ImageReady™ MR Conditional Pacing System in China |
Figure 4‑157: Micra Transcatheter Pacing System Continued Access Study Protocol |
Figure 4‑158: Extravascular ICD Pivotal Study (EV ICD) |
Figure 4‑159: Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement (T-DEF) |
Figure 4‑160: Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead |
Figure 4‑161: A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging (ASIA MRI ICD) |
Figure 4‑162: Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing (MODULAR ATP) |
Figure 4‑163: Acute Feasibility Investigation of a New S-ICD Electrode (ASE) |
Figure 4‑164: Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) |
Figure 4‑165: A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy (PRAETORIAN) |
Figure 4‑166: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT) |
Figure 4‑167: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use of a VDD-ICD Lead (Dx-AF) |
Figure 4‑168: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD) |
Figure 4‑169: Extravascular ICD Pilot Study |
Figure 4‑170: Acute Feasibility Investigation of a New S-ICD Electrode |
Figure 4‑171: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of Sudden Cardiac Death |
Figure 4‑172: BIO|MASTER.Ilivia Family/Plexa |
Figure 4‑173: Metabolic Mapping and Cardiac Resynchronization |
Figure 4‑174: CRT-P or CRT-D in Dilated Cardiomyopathy (CRT-REALITY) |
Figure 4‑175: Safety and Performance Aspects of CRT-DX System in Patients with Sinus Rhythm (BIO|REDUCE) |
Figure 4‑176: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus Conventional Pacing in CRT candidates: TRIPLEAD Trial |
Figure 4‑177: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure |
Figure 4‑178: The His Optimised Pacing Evaluated for Heart Failure Trial (HOPE-HF) |
Figure 4‑179: Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failure With Preserved Ejection Fraction (PREFECTUS) |
Figure 4‑180: Cardiac Resynchronization in the Elderly |
Figure 4‑181: Standard Care Versus Triventricular Pacing in Heart Failure (STRIVE HF) |
Figure 4‑182: Responders and Quadripolar LV Lead in CRT |
Figure 4‑183: Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS |
Figure 4‑184: SD01 Master Study (Safety and Efficacy Study) |
Figure 4‑185: Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy (ASTRAL-4LV) |
Figure 4‑186: Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO) |
Figure 4‑187: Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 Connector (FRIENDS) |
Figure 4‑188: Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector (NAVIGATOR) |
Figure 4‑189: Avoid Transvenous Leads in Appropriate Subjects |
Figure 4‑190: Left Ventricular Septal Pacing: Potential Application for Cardiac Resynchronization Therapy |
Figure 4‑191: Quartet Lead and Resynchronization Therapy Options |
Figure 4‑192: Attain Stability™ Quad Clinical Study |
Figure 4‑193: The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Persistent Atrial Fibrillation |
Figure 4‑194: Reverse RAMP Pacing to Terminate Ventricular Tachycardia (REV-RAMP) |
Figure 4‑195: AXONE -Acute: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronization Therapy |
Figure 4‑196: A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an Investigational Device Exemption (IDE) Study |
Figure 4‑197: Acute Study to Collect Electrical Signals From the Heart Using a Special Lead |
Figure 4‑198: RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation (MAP-AF) |
Figure 4‑199: RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY) |
Figure 4‑200: Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib |
Figure 4‑201: Esophageal 3D Mapping System for Cardiac Arrhythmias |
Figure 4‑202: The Basel CardioInsightTM - 3D Mapping Study (BigMap) |
Figure 4‑203: Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias |
Figure 4‑204: RADAR Clinical Trial |
Figure 4‑205: EnSite™ HD Grid Catheter Mapping Study |
Figure 4‑206: Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias |
Figure 4‑207: Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment |
Figure 4‑208: An Evaluation of the Safety and Performance of the CathVision Cube® System |
Figure 4‑209: The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System |
Figure 4‑210: Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development |
Figure 4‑211: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation |
Figure 4‑212: ICE Based Atrial Flutter Ablation Vs Conventional Fluoroscopy/Anatomical Mapping Based Ablation - ICE Flutter Study |
Figure 4‑213: Philips Intracardiac Echocardiography (ICE) Clinical Registry |
Figure 4‑214: Foresight Intracardiac Echocardiography (ICE) System |
Figure 4‑215: INtra-procedural ultraSound Imaging During Isolation of the Pulmonary Veins |
Figure 4‑216: EnSite Precision™ 2.0 Registry |
Figure 4‑217: Foresight Intracardiac Echocardiography (ICE) System |
Figure 4‑218: EPICADIA - Electrophysiologic Performance Investigation for CArdiac DIAgnosis |
Figure 4‑219: Esophageal 3D Mapping System for Cardiac Arrhythmias: esoECG-3D |
Figure 4‑220: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia |
Figure 4‑221: DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness |
Figure 4‑222: FIRE AND ICE II Trial Pilot |
Figure 4‑223: TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study (TactiCathPAS) |
Figure 4‑224: Abbott Atrial Fibrillation Post Approval Study |
Figure 4‑225: Cryotherapy Versus Radiofrequency Catheter Ablation Research Program |
Figure 4‑226: Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR) |
Figure 4‑227: Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation (NEwTON AF) |
Figure 4‑228: Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation |
Figure 4‑229: Comparison of Contact-force Monitoring Irrigated Tip Catheter and Mesh-like Irrigated Tip Catheter in Atrial Fibrillation Ablation: Prospective Randomized Trial (COMMIC Trial) |
Figure 4‑230: Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success |
Figure 4‑231: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter |
Figure 4‑232: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation |
Figure 4‑233: CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial |
Figure 4‑234: AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment (ICE-AFIB) |
Figure 4‑235: FREEZE-AFIB Post-Market Study |
Figure 4‑236: Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter |
Figure 4‑237: Ablation STrategies for Repeat PrOcedures in Patients With Atrial Fibrillation Recurrences (ASTRO AF) |
Figure 4‑238: ArcticLine Feasibility Study |
Figure 4‑239: A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation |
Figure 4‑240: A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent Atrial Fibrilation |
Figure 4‑241: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation |
Figure 4‑242: A Comparison of Radiofrequency Catheter Ablation With or Without Contact-force and Cryoablation for Paroxysmal Atrial Fibrillation Ablation |
Figure 4‑243: A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects With Atrial Flutter |
Figure 4‑244: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study) |
Figure 4‑245: STOP Persistent AF |
Figure 4‑246: Cryoablation of Atrial Fibrillation in Patients With Severe Heart Failure |
Figure 4‑247: Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation |
Figure 4‑248: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study) |
Figure 4‑249: CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation |
Figure 4‑250: Outcomes of Second-Generation Laser Balloon Ablation for Atrial Fibrillation (LIGHT-AF) |
Figure 4‑251: Laser Ablation Study for trEatment of atRial Fibrillation (LASER) |
Figure 5‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 5‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Region, Global, 2018 – 2028 (US$M) |
Figure 5‑3: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2021 (1 of 2) |
Figure 5‑4: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2021 (2 of 2) |
Figure 5‑5: SWOT Analysis, Abbott (1 of 2) |
Figure 5‑6: SWOT Analysis, Abbott (2 of 2) |
Figure 5‑7: SWOT Analysis, Biosense Webster (1 of 2) |
Figure 5‑8: SWOT Analysis, Biosense Webster (2 of 2) |
Figure 5‑9: SWOT Analysis, Biotronik (1 of 2) |
Figure 5‑10: SWOT Analysis, Biotronik (2 of 2) |
Figure 5‑11: SWOT Analysis, Boston Scientific (1 of 2) |
Figure 5‑12: SWOT Analysis, Boston Scientific (2 of 2) |
Figure 5‑13: SWOT Analysis, GE Healthcare (1 of 2) |
Figure 5‑14: SWOT Analysis, GE Healthcare (2 of 2) |
Figure 5‑15: SWOT Analysis, Medtronic (1 of 2) |
Figure 5‑16: SWOT Analysis, Medtronic (2 of 2) |
Figure 5‑17: SWOT Analysis, MicroPort (1 of 2) |
Figure 5‑18: SWOT Analysis, MicroPort (2 of 2) |
Figure 6‑1: Pacemaker Procedures Covered |
Figure 6‑2: Pacemaker Markets Covered |
Figure 6‑3: Pacemaker Regions Covered, Global (1 of 2) |
Figure 6‑4: Pacemaker Regions Covered, Global (2 of 2) |
Figure 6‑5: Pacemaker Placement Procedures by Segment, Global, 2018 – 2028 |
Figure 6‑6: Pacemaker Placement Procedures by Region, Global, 2018 – 2028 |
Figure 6‑7: Pacemaker Placement Procedures by Country, North America, 2018 – 2028 |
Figure 6‑8: Pacemaker Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 6‑9: Pacemaker Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 6‑10: Pacemaker Placement Procedures by Country, Western Europe, 2018 – 2028 |
Figure 6‑11: Pacemaker Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 6‑12: Pacemaker Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 6‑13: Pacemaker Placement Procedures by Country, Middle East, 2018 – 2028 |
Figure 6‑14: Pacemaker Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 6‑15: Pacemaker Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 6‑16: Pacemaker Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 6‑17: Pacemaker Placement Procedures by Country, Africa, 2018 – 2028 |
Figure 6‑18: Initial Placement Pacemaker Procedures by Region, Global, 2018 – 2028 |
Figure 6‑19: Initial Placement Pacemaker Procedures by Country, North America, 2018 – 2028 |
Figure 6‑20: Initial Placement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 6‑21: Initial Placement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 6‑22: Initial Placement Pacemaker Procedures by Country, Western Europe, 2018 – 2028 |
Figure 6‑23: Initial Placement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 6‑24: Initial Placement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 6‑25: Initial Placement Pacemaker Procedures by Country, Middle East, 2018 – 2028 |
Figure 6‑26: Initial Placement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 6‑27: Initial Placement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 6‑28: Initial Placement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 6‑29: Initial Placement Pacemaker Procedures by Country, Africa, 2018 – 2028 |
Figure 6‑30: Replacement Pacemaker Procedures by Region, Global, 2018 – 2028 |
Figure 6‑31: Replacement Pacemaker Procedures by Country, North America, 2018 – 2028 |
Figure 6‑32: Replacement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 6‑33: Replacement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 6‑34: Replacement Pacemaker Procedures by Country, Western Europe, 2018 – 2028 |
Figure 6‑35: Replacement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 6‑36: Replacement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 6‑37: Replacement Pacemaker Procedures by Country, Middle East, 2018 – 2028 |
Figure 6‑38: Replacement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 6‑39: Replacement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 6‑40: Replacement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 6‑41: Replacement Pacemaker Procedures by Country, Africa, 2018 – 2028 |
Figure 6‑42: Pacemaker Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 6‑43: Pacemaker Market by Region, Global, 2018 – 2028 (US$M) |
Figure 6‑44: Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑45: Units Sold by Region, Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑46: Average Selling Price by Region, Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑47: Market Value by Region, Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑48: Single-Chamber Pacemaker Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 6‑49: Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑50: Units Sold by Region, Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑51: Average Selling Price by Region, Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑52: Market Value by Region, Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑53: Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑54: Units Sold by Region, Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑55: Average Selling Price by Region, Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑56: Market Value by Region, Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑57: Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑58: Units Sold by Region, Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑59: Average Selling Price by Region, Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑60: Market Value by Region, Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑61: Dual-Chamber Pacemaker Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 6‑62: Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑63: Units Sold by Region, Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑64: Average Selling Price by Region, Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑65: Market Value by Region, Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑66: Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑67: Units Sold by Region, Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑68: Average Selling Price by Region, Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑69: Market Value by Region, Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑70: Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑71: Units Sold by Region, Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑72: Average Selling Price by Region, Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑73: Market Value by Region, Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑74: Leadless Pacemaker Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 6‑75: Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑76: Units Sold by Region, Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑77: Average Selling Price by Region, Leadless Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑78: Market Value by Region, Leadless Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑79: Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑80: Units Sold by Region, Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑81: Average Selling Price by Region, Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑82: Market Value by Region, Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑83: Replacement Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑84: Units Sold by Region, Replacement Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑85: Average Selling Price by Region, Replacement Leadless Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑86: Market Value by Region, Replacement Leadless Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑87: Leading Competitors, Pacemaker Market, Global, 2021 |
Figure 6‑88: Leading Competitors by Region, Pacemaker Market, Global, 2021 |
Figure 6‑89: Leading Competitors by Region, Single-Chamber Pacemaker Market, Global, 2021 |
Figure 6‑90: Leading Competitors by Region, Dual-Chamber Pacemaker Market, Global, 2021 |
Figure 7‑1: ICD Procedures Covered |
Figure 7‑2: ICD Markets Covered |
Figure 7‑3: ICD Regions Covered, Global (1 of 2) |
Figure 7‑4: ICD Regions Covered, Global (2 of 2) |
Figure 7‑5: ICD Placement Procedures by Segment, Global, 2018 – 2028 |
Figure 7‑6: ICD Placement Procedures by Region, Global, 2018 – 2028 |
Figure 7‑7: ICD Placement Procedures by Country, North America, 2018 – 2028 |
Figure 7‑8: ICD Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 7‑9: ICD Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 7‑10: ICD Placement Procedures by Country, Western Europe, 2018 – 2028 |
Figure 7‑11: ICD Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 7‑12: ICD Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 7‑13: ICD Placement Procedures by Country, Middle East, 2018 – 2028 |
Figure 7‑14: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 7‑15: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 7‑16: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 7‑17: ICD Placement Procedures by Country, Africa, 2018 – 2028 |
Figure 7‑18: Initial Placement ICD Procedures by Region, Global, 2018 – 2028 |
Figure 7‑19: Initial Placement ICD Procedures by Country, North America, 2018 – 2028 |
Figure 7‑20: Initial Placement ICD Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 7‑21: Initial Placement ICD Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 7‑22: Initial Placement ICD Procedures by Country, Western Europe, 2018 – 2028 |
Figure 7‑23: Initial Placement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 7‑24: Initial Placement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 7‑25: Initial Placement ICD Procedures by Country, Middle East, 2018 – 2028 |
Figure 7‑26: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 7‑27: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 7‑28: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 7‑29: Initial Placement ICD Procedures by Country, Africa, 2018 – 2028 |
Figure 7‑30: Replacement ICD Procedures by Region, Global, 2018 – 2028 |
Figure 7‑31: Replacement ICD Procedures by Country, North America, 2018 – 2028 |
Figure 7‑32: Replacement ICD Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 7‑33: Replacement ICD Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 7‑34: Replacement ICD Procedures by Country, Western Europe, 2018 – 2028 |
Figure 7‑35: Replacement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 7‑36: Replacement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 7‑37: Replacement ICD Procedures by Country, Middle East, 2018 – 2028 |
Figure 7‑38: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 7‑39: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 7‑40: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 7‑41: Replacement ICD Procedures by Country, Africa, 2018 – 2028 |
Figure 7‑42: ICD Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 7‑43: ICD Market by Region, Global, 2018 – 2028 (US$M) |
Figure 7‑44: ICD Market, Global, 2018 – 2028 |
Figure 7‑45: Units Sold by Region, ICD Market, Global, 2018 – 2028 |
Figure 7‑46: Average Selling Price by Region, ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑47: Market Value by Region, ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑48: Single-Chamber ICD Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 7‑49: Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑50: Units Sold by Region, Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑51: Average Selling Price by Region, Single-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑52: Market Value by Region, Single-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑53: Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑54: Units Sold by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑55: Average Selling Price by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑56: Market Value by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑57: Replacement Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑58: Units Sold by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑59: Average Selling Price by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑60: Market Value by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑61: Dual-Chamber ICD Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 7‑62: Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑63: Units Sold by Region, Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑64: Average Selling Price by Region, Dual-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑65: Market Value by Region, Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑66: Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑67: Units Sold by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑68: Average Selling Price by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑69: Market Value by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑70: Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑71: Units Sold by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑72: Average Selling Price by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑73: Market Value by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑74: S-ICD Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 7‑75: S-ICD Market, Global, 2018 – 2028 |
Figure 7‑76: Units Sold by Region, S-ICD Market, Global, 2018 – 2028 |
Figure 7‑77: Average Selling Price by Region, S-ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑78: Market Value by Region, S-ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑79: Initial Placement S-ICD Market, Global, 2018 – 2028 |
Figure 7‑80: Units Sold by Region, Initial Placement S-ICD Market, Global, 2018 – 2028 |
Figure 7‑81: Average Selling Price by Region, Initial Placement S-ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑82: Market Value by Region, Initial Placement S-ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑83: Replacement S-ICD Market, Global, 2018 – 2028 |
Figure 7‑84: Units Sold by Region, Replacement S-ICD Market, Global, 2018 – 2028 |
Figure 7‑85: Average Selling Price by Region, Replacement S-ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑86: Market Value by Region, Replacement S-ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑87: Leading Competitors, ICD Market, Global, 2021 |
Figure 7‑88: Leading Competitors by Region, ICD Market, Global, 2021 |
Figure 7‑89: Leading Competitors by Region, Single-Chamber ICD Market, Global, 2021 |
Figure 7‑90: Leading Competitors by Region, Dual-Chamber ICD Market, Global, 2021 |
Figure 8‑1: CRT Device Procedures Covered |
Figure 8‑2: CRT Device Markets Covered |
Figure 8‑3: CRT Device Regions Covered, Global (1 of 2) |
Figure 8‑4: CRT Device Regions Covered, Global (2 of 2) |
Figure 8‑5: CRT Placement Procedures by Segment, Global, 2018 – 2028 |
Figure 8‑6: CRT Placement Procedures by Region, Global, 2018 – 2028 |
Figure 8‑7: CRT Placement Procedures by Country, North America, 2018 – 2028 |
Figure 8‑8: CRT Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 8‑9: CRT Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 8‑10: CRT Placement Procedures by Country, Western Europe, 2018 – 2028 |
Figure 8‑11: CRT Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 8‑12: CRT Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 8‑13: CRT Placement Procedures by Country, Middle East, 2018 – 2028 |
Figure 8‑14: CRT Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 8‑15: CRT Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 8‑16: CRT Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 8‑17: CRT Placement Procedures by Country, Africa, 2018 – 2028 |
Figure 8‑18: Initial Placement CRT Procedures by Region, Global, 2018 – 2028 |
Figure 8‑19: Initial Placement CRT Procedures by Country, North America, 2018 – 2028 |
Figure 8‑20: Initial Placement CRT Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 8‑21: Initial Placement CRT Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 8‑22: Initial Placement CRT Procedures by Country, Western Europe, 2018 – 2028 |
Figure 8‑23: Initial Placement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 8‑24: Initial Placement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 8‑25: Initial Placement CRT Procedures by Country, Middle East, 2018 – 2028 |
Figure 8‑26: Initial Placement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 8‑27: Initial Placement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 8‑28: Initial Placement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 8‑29: Initial Placement CRT Procedures by Country, Africa, 2018 – 2028 |
Figure 8‑30: Replacement CRT Procedures by Region, Global, 2018 – 2028 |
Figure 8‑31: Replacement CRT Procedures by Country, North America, 2018 – 2028 |
Figure 8‑32: Replacement CRT Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 8‑33: Replacement CRT Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 8‑34: Replacement CRT Procedures by Country, Western Europe, 2018 – 2028 |
Figure 8‑35: Replacement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 8‑36: Replacement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 8‑37: Replacement CRT Procedures by Country, Middle East, 2018 – 2028 |
Figure 8‑38: Replacement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 8‑39: Replacement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 8‑40: Replacement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 8‑41: Replacement CRT Procedures by Country, Africa, 2018 – 2028 |
Figure 8‑42: CRT Device Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 8‑43: CRT Device Market by Region, Global, 2018 – 2028 (US$M) |
Figure 8‑44: CRT Device Market, Global, 2018 – 2028 |
Figure 8‑45: Units Sold by Region, CRT Device Market, Global, 2018 – 2028 |
Figure 8‑46: Average Selling Price by Region, CRT Device Market, Global, 2018 – 2028 (US$) |
Figure 8‑47: Market Value by Region, CRT Device Market, Global, 2018 – 2028 (US$M) |
Figure 8‑48: CRT-P Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 8‑49: CRT-P Market, Global, 2018 – 2028 |
Figure 8‑50: Units Sold by Region, CRT-P Market, Global, 2018 – 2028 |
Figure 8‑51: Average Selling Price by Region, CRT-P Market, Global, 2018 – 2028 (US$) |
Figure 8‑52: Market Value by Region, CRT-P Market, Global, 2018 – 2028 (US$M) |
Figure 8‑53: Initial Placement CRT-P Market, Global, 2018 – 2028 |
Figure 8‑54: Units Sold by Region, Initial Placement CRT-P Market, Global, 2018 – 2028 |
Figure 8‑55: Average Selling Price by Region, Initial Placement CRT-P Market, Global, 2018 – 2028 (US$) |
Figure 8‑56: Market Value by Region, Initial Placement CRT-P Market, Global, 2018 – 2028 (US$M) |
Figure 8‑57: Replacement CRT-P Market, Global, 2018 – 2028 |
Figure 8‑58: Units Sold by Region, Replacement CRT-P Market, Global, 2018 – 2028 |
Figure 8‑59: Average Selling Price by Region, Replacement CRT-P Market, Global, 2018 – 2028 (US$) |
Figure 8‑60: Market Value by Region, Replacement CRT-P Market, Global, 2018 – 2028 (US$M) |
Figure 8‑61: CRT-D Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 8‑62: CRT-D Market, Global, 2018 – 2028 |
Figure 8‑63: Units Sold by Region, CRT-D Market, Global, 2018 – 2028 |
Figure 8‑64: Average Selling Price by Region, CRT-D Market, Global, 2018 – 2028 (US$) |
Figure 8‑65: Market Value by Region, CRT-D Market, Global, 2018 – 2028 (US$M) |
Figure 8‑66: Initial Placement CRT-D Market, Global, 2018 – 2028 |
Figure 8‑67: Units Sold by Region, Initial Placement CRT-D Market, Global, 2018 – 2028 |
Figure 8‑68: Average Selling Price by Region, Initial Placement CRT-D Market, Global, 2018 – 2028 (US$) |
Figure 8‑69: Market Value by Region, Initial Placement CRT-D Market, Global, 2018 – 2028 (US$M) |
Figure 8‑70: Replacement CRT-D Market, Global, 2018 – 2028 |
Figure 8‑71: Units Sold by Region, Replacement CRT-D Market, Global, 2018 – 2028 |
Figure 8‑72: Average Selling Price by Region, Replacement CRT-D Market, Global, 2018 – 2028 (US$) |
Figure 8‑73: Market Value by Region, Replacement CRT-D Market, Global, 2018 – 2028 (US$M) |
Figure 8‑74: Leading Competitors, CRT Device Market, Global, 2021 |
Figure 8‑75: Leading Competitors by Region, CRT Device Market, Global, 2021 |
Figure 8‑76: Leading Competitors by Region, CRT-P Market, Global, 2021 |
Figure 8‑77: Leading Competitors by Region, CRT-DMarket, Global, 2021 |
Figure 9‑1: Cardiac Lead Markets Covered |
Figure 9‑2: Cardiac Lead Regions Covered, Global (1 of 2) |
Figure 9‑3: Cardiac Lead Regions Covered, Global (2 of 2) |
Figure 9‑4: Cardiac Lead Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 9‑5: Cardiac Lead Market by Region, Global, 2018 – 2028 (US$M) |
Figure 9‑6: Cardiac Lead Market, Global, 2018 – 2028 |
Figure 9‑7: Units Sold by Region, Cardiac Lead Market, Global, 2018 – 2028 |
Figure 9‑8: Average Selling Price by Region, Cardiac Lead Market, Global, 2018 – 2028 (US$) |
Figure 9‑9: Market Value by Region, Cardiac Lead Market, Global, 2018 – 2028 (US$M) |
Figure 9‑10: Pacing Lead Market, Global, 2018 – 2028 |
Figure 9‑11: Units Sold by Region, Pacing Lead Market, Global, 2018 – 2028 |
Figure 9‑12: Average Selling Price by Region, Pacing Lead Market, Global, 2018 – 2028 (US$) |
Figure 9‑13: Market Value by Region, Pacing Lead Market, Global, 2018 – 2028 (US$M) |
Figure 9‑14: Defibrillation Lead Market, Global, 2018 – 2028 |
Figure 9‑15: Units Sold by Region, Defibrillation Lead Market, Global, 2018 – 2028 |
Figure 9‑16: Average Selling Price by Region, Defibrillation Lead Market, Global, 2018 – 2028 (US$) |
Figure 9‑17: Market Value by Region, Defibrillation Lead Market, Global, 2018 – 2028 (US$M) |
Figure 9‑18: LV Lead Market, Global, 2018 – 2028 |
Figure 9‑19: Units Sold by Region, LV Lead Market, Global, 2018 – 2028 |
Figure 9‑20: Average Selling Price by Region, LV Lead Market, Global, 2018 – 2028 (US$) |
Figure 9‑21: Market Value by Region, LV Lead Market, Global, 2018 – 2028 (US$M) |
Figure 9‑22: Leading Competitors, Cardiac Lead Market, Global, 2021 |
Figure 9‑23: Leading Competitors by Region, Cardiac Lead Market, Global, 2021 |
Figure 9‑24: Leading Competitors by Region, Pacing Lead Market, Global, 2021 |
Figure 9‑25: Leading Competitors by Region, Defibrillation Lead Market, Global, 2021 |
Figure 9‑26: Leading Competitors by Region, LV Lead Market, Global, 2021 |
Figure 10‑1: Implantable Loop Recorder Regions Covered, Global (1 of 2) |
Figure 10‑2: Implantable Loop Recorder Regions Covered, Global (2 of 2) |
Figure 10‑3: Implantable Loop Recorder Placement Procedures by Region, Global, 2018 – 2028 |
Figure 10‑4: Implantable Loop Recorder Placement Procedures by Country, North America, 2018 – 2028 |
Figure 10‑5: Implantable Loop Recorder Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 10‑6: Implantable Loop Recorder Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 10‑7: Implantable Loop Recorder Placement Procedures by Country, Western Europe, 2018 – 2028 |
Figure 10‑8: Implantable Loop Recorder Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 10‑9: Implantable Loop Recorder Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 10‑10: Implantable Loop Recorder Placement Procedures by Country, Middle East, 2018 – 2028 |
Figure 10‑11: Implantable Loop Recorder Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 10‑12: Implantable Loop Recorder Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 10‑13: Implantable Loop Recorder Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 10‑14: Implantable Loop Recorder Placement Procedures by Country, Africa, 2018 – 2028 |
Figure 10‑15: Implantable Loop Recorder Market, Global, 2018 – 2028 |
Figure 10‑16: Units Sold by Region, Implantable Loop Recorder Market, Global, 2018 – 2028 |
Figure 10‑17: Average Selling Price by Region, Implantable Loop Recorder Market, Global, 2018 – 2028 (US$) |
Figure 10‑18: Market Value by Region, Implantable Loop Recorder Market, Global, 2018 – 2028 (US$M) |
Figure 10‑19: Leading Competitors, Implantable Loop Recorder Market, Global, 2021 |
Figure 11‑1: Electrophysiology Lab System Markets Covered |
Figure 11‑2: Electrophysiology Lab System Regions Covered, Global (1 of 2) |
Figure 11‑3: Electrophysiology Lab System Regions Covered, Global (2 of 2) |
Figure 11‑4: Electrophysiology Lab System Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 11‑5: Electrophysiology Lab System Market by Region, Global, 2018 – 2028 (US$M) |
Figure 11‑6: Electrophysiology Lab System Market, Global, 2018 – 2028 |
Figure 11‑7: Units Sold by Region, Electrophysiology Lab System Market, Global, 2018 – 2028 |
Figure 11‑8: Average Selling Price by Region, Electrophysiology Lab System Market, Global, 2018 – 2028 (US$) |
Figure 11‑9: Market Value by Region, Electrophysiology Lab System Market, Global, 2018 – 2028 (US$M) |
Figure 11‑10: 3D Mapping System Market, Global, 2018 – 2028 |
Figure 11‑11: Units Sold by Region, 3D Mapping System Market, Global, 2018 – 2028 |
Figure 11‑12: Average Selling Price by Region, 3D Mapping System Market, Global, 2018 – 2028 (US$) |
Figure 11‑13: Market Value by Region, 3D Mapping System Market, Global, 2018 – 2028 (US$M) |
Figure 11‑14: EP Recording System Market, Global, 2018 – 2028 |
Figure 11‑15: Units Sold by Region, EP Recording System Market, Global, 2018 – 2028 |
Figure 11‑16: Average Selling Price by Region, EP Recording System Market, Global, 2018 – 2028 (US$) |
Figure 11‑17: Market Value by Region, EP Recording System Market, Global, 2018 – 2028 (US$M) |
Figure 11‑18: Leading Competitors, Electrophysiology Lab System Market, Global, 2021 |
Figure 12‑1: Diagnostic Electrophysiology Catheter Markets Covered |
Figure 12‑2: Diagnostic Electrophysiology Catheter Regions Covered, Global (1 of 2) |
Figure 12‑3: Diagnostic Electrophysiology Catheter Regions Covered, Global (2 of 2) |
Figure 12‑4: Diagnostic Electrophysiology Procedures by Region, Global, 2018 – 2028 |
Figure 12‑5: Diagnostic Electrophysiology Procedures by Country, North America, 2018 – 2028 |
Figure 12‑6: Diagnostic Electrophysiology Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 12‑7: Diagnostic Electrophysiology Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 12‑8: Diagnostic Electrophysiology Procedures by Country, Western Europe, 2018 – 2028 |
Figure 12‑9: Diagnostic Electrophysiology Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 12‑10: Diagnostic Electrophysiology Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 12‑11: Diagnostic Electrophysiology Procedures by Country, Middle East, 2018 – 2028 |
Figure 12‑12: Diagnostic Electrophysiology Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 12‑13: Diagnostic Electrophysiology Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 12‑14: Diagnostic Electrophysiology Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 12‑15: Diagnostic Electrophysiology Procedures by Country, Africa, 2018 – 2028 |
Figure 12‑16: Diagnostic Electrophysiology Catheter Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 12‑17: Diagnostic Electrophysiology Catheter Market by Region, Global, 2018 – 2028 (US$M) |
Figure 12‑18: Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑19: Units Sold by Region, Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑20: Average Selling Price by Region, Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 (US$) |
Figure 12‑21: Market Value by Region, Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 12‑22: Conventional Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑23: Units Sold by Region, Conventional Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑24: Average Selling Price by Region, Conventional Electrophysiology Catheter Market, Global, 2018 – 2028 (US$) |
Figure 12‑25: Market Value by Region, Conventional Electrophysiology Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 12‑26: Advanced Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑27: Units Sold by Region, Advanced Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑28: Average Selling Price by Region, Advanced Electrophysiology Catheter Market, Global, 2018 – 2028 (US$) |
Figure 12‑29: Market Value by Region, Advanced Electrophysiology Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 12‑30: ICE Catheter Market, Global, 2018 – 2028 |
Figure 12‑31: Units Sold by Region, ICE Catheter Market, Global, 2018 – 2028 |
Figure 12‑32: Average Selling Price by Region, ICE Catheter Market, Global, 2018 – 2028 (US$) |
Figure 12‑33: Market Value by Region, ICE Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 12‑34: Leading Competitors, Diagnostic Electrophysiology Catheter Market, Global, 2021 |
Figure 13‑1: Cardiac Ablation Catheter Procedures Covered |
Figure 13‑2: Cardiac Ablation Catheter Markets Covered |
Figure 13‑3: Cardiac Ablation Catheter Regions Covered, Global (1 of 2) |
Figure 13‑4: Cardiac Ablation Catheter Regions Covered, Global (2 of 2) |
Figure 13‑5: Cardiac Ablation Procedures by Segment, Global, 2018 – 2028 |
Figure 13‑6: Cardiac Ablation Procedures by Region, Global, 2018 – 2028 |
Figure 13‑7: Cardiac Ablation Procedures by Country, North America, 2018 – 2028 |
Figure 13‑8: Cardiac Ablation Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 13‑9: Cardiac Ablation Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 13‑10: Cardiac Ablation Procedures by Country, Western Europe, 2018 – 2028 |
Figure 13‑11: Cardiac Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 13‑12: Cardiac Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 13‑13: Cardiac Ablation Procedures by Country, Middle East, 2018 – 2028 |
Figure 13‑14: Cardiac Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 13‑15: Cardiac Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 13‑16: Cardiac Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 13‑17: Cardiac Ablation Procedures by Country, Africa, 2018 – 2028 |
Figure 13‑18: RF Ablation Procedures by Region, Global, 2018 – 2028 |
Figure 13‑19: RF Ablation Procedures by Country, North America, 2018 – 2028 |
Figure 13‑20: RF Ablation Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 13‑21: RF Ablation Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 13‑22: RF Ablation Procedures by Country, Western Europe, 2018 – 2028 |
Figure 13‑23: RF Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 13‑24: RF Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 13‑25: RF Ablation Procedures by Country, Middle East, 2018 – 2028 |
Figure 13‑26: RF Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 13‑27: RF Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 13‑28: RF Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 13‑29: RF Ablation Procedures by Country, Africa, 2018 – 2028 |
Figure 13‑30: Cryoablation Procedures by Region, Global, 2018 – 2028 |
Figure 13‑31: Cryoablation Procedures by Country, North America, 2018 – 2028 |
Figure 13‑32: Cryoablation Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 13‑33: Cryoablation Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 13‑34: Cryoablation Procedures by Country, Western Europe, 2018 – 2028 |
Figure 13‑35: Cryoablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 13‑36: Cryoablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 13‑37: Cryoablation Procedures by Country, Middle East, 2018 – 2028 |
Figure 13‑38: Cryoablation Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 13‑39: Cryoablation Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 13‑40: Cryoablation Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 13‑41: Cryoablation Procedures by Country, Africa, 2018 – 2028 |
Figure 13‑42: Cardiac Ablation Catheter Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 13‑43: Cardiac Ablation Catheter Market by Region, Global, 2018 – 2028 (US$M) |
Figure 13‑44: Cardiac Ablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑45: Units Sold by Region, Cardiac Ablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑46: Average Selling Price by Region, Cardiac Ablation Catheter Market, Global, 2018 – 2028 (US$) |
Figure 13‑47: Market Value by Region, Cardiac Ablation Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 13‑48: RF Ablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑49: Units Sold by Region, RF Ablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑50: Average Selling Price by Region, RF Ablation Catheter Market, Global, 2018 – 2028 (US$) |
Figure 13‑51: Market Value by Region, RF Ablation Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 13‑52: Cryoablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑53: Units Sold by Region, Cryoablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑54: Average Selling Price by Region, Cryoablation Catheter Market, Global, 2018 – 2028 (US$) |
Figure 13‑55: Market Value by Region, Cryoablation Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 13‑56: Leading Competitors, Cardiac Ablation Catheter Market, Global, 2021 |
Figure 13‑57: Leading Competitors by Region, Cardiac Ablation Catheter Market, Global, 2021 |
Figure 13‑58: Leading Competitors by Region, RF Ablation Catheter Market, Global, 2021 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
Report Summary | FREE |
Cardiac Rhythm Management Market Size, Share, & COVID-19 Impact Analysis | Global | 2022-2028 | MedSuite | Includes: Pacemakers, Cardiac Ablation Catheters, and 6 more
$9,995 – $13,995
The full report suite on the global market for cardiac rhythm management, electrophysiology & cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, implantable loop recorders (ILRs), electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.
- 2022
- 10 Years
- Global
- 11/24/2022
- 755
- MedSuite



